Filter by type Show all Pages Solutions Expertise Reports News Webinars Locations FAQs Case Studies Whitepapers Filter By Any Pages Solutions Expertise Reports News Webinars Locations FAQs Case Studies Whitepapers October 7, 2022 News Featured in the endpoints news- the factors driving a rapid evolution of gene & cell therapy and… APAC is the fast growing region globally for cell & gene therapy trials representing Read more September 15, 2022 News Novotech Presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia… Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene T Read more February 2, 2023 News Asia Pacific Cell & Gene Research Growing 50% Faster than ROW Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Read more February 10, 2023 News Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phas Read more July 19, 2022 News Novotech and Endpoints Present “Evolution of Cell & Gene Therapy in China: The Case for Universal… Sydney - Novotech, the leading Asia Pacific biotech specialist CRO with expanded Read more February 5, 2020 Report Accelerating Genetic Therapy Clinical Trials in Asia-Pacific A growing number of biotechnology companies, both in the West and in Asia, are specializing in gene therapies and other regenerative treatments boosted by the approval of the first genetic therapy Download Expertise GMO Solutions Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Reg November 9, 2021 News Novotech Platinum Sponsor at ChinaTrials13 Summit Shanghai 2021 Sydney - Novotech, a leading biotech specialist CRO in the Asia-Pacific region, Read more November 22, 2019 News Novotech’s Clinical Network Services wins GENE Awards for Industry excellence in biotech drug… Clinical Network Services, a subsidiary of Novotech, the Asia-Pacific CRO, was awarded a prestigi Read more September 26, 2022 Whitepaper Cell & Gene Therapy Growth comparison of Asia Pacific, particularly China versus rest of the world between 2017 and 2021, shows China hav Download September 30, 2022 FAQ Bioinformatics Bioinformatics is the scientific discipline that includes the use of computers to collect, store and analyse information relating to biological data. Read More September 12, 2022 FAQ Pharmacogenomics Pharmacogenomics is the study of how a person’s DNA responds to drugs. Read More Expertise Drug Development Consulting Novotech Drug Development Consulting March 3, 2023 News Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trial Read more July 19, 2021 Webinar Expedited clinical development strategies for China Arsalan Arif: Hi, everyone. Watch June 30, 2022 News Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022 Seoul, South Korea - Novotech, the leading Asia Pacific biotech specialist CRO w Read more June 28, 2022 Whitepaper The role of real world evidence to support US FDA and TGA registrations Real world evidence (RWE) can contribute valuable information to new medicine registrations, in particular for diseases that are difficult to assess in randomized clinical trials (RCTs) and for emerging technologies such as gene and cell therapies to help enhance our understanding of such products. Download November 14, 2022 News Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy Novotech has recently been benchmarked as a top 10 CRO among the world’s leading CROs, is a final Read more September 21, 2022 FAQ DNA and RNA DNA (Deoxyribonucleic Acid) is the genetic material found inside cells responsible for a living organism's development and function. Read More December 11, 2017 News TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence:… TheraVida Initiates Phase 2 Trial of T Read more December 16, 2022 News CEO End of year announcement December 2022 Read more October 7, 2022 News Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CR Read more March 7, 2023 News Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations Singapore - Novotech, the leading Asia Pacific centred biotech CRO will be at BI Read more October 20, 2022 News The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar f Read more December 6, 2022 News Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sulli Read more January 10, 2023 News Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug… Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR In Read more March 14, 2023 News Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published Read more January 10, 2023 News Novotech Acquires European CRO – Strengthens Global Operations Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and r Read more October 26, 2022 News Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the late Read more December 19, 2022 News Novotech is Gold Sponsor at Biotech Showcase 2023 Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Read more January 5, 2023 News Novotech Team Joins BIO Partnering at JPM 2023 Novotech, the Asia Pacific centered biotech specialist CRO, will attend JPM 2023 and experts from Read more October 12, 2022 News Novotech India Recognised as “Best Workplaces for Women 2022” by Global Work Standards Authority Novotech, the leading Asia Pacific biotech specialist CRO, has again received “Best Workplace” ce Read more December 15, 2022 News Data Shows 50% of New Trials Have Sites in Asia Pacific Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publ Read more December 21, 2022 News Novotech Sponsors “The Next Big Thing in Cancer Care” Webinar - CAR-T, Precision Oncology, AI and… Novotech, the Asia Pacific centered biotech specialist CRO, presents “The Next Big Thing in Cance Read more July 15, 2020 Webinar Advancing oncology trials in Asia-Pacific Arsalan Arif: Watch September 5, 2022 News Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC Meet the team at Booth #409 Read more Solution Real world data June 2, 2022 News Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and… Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded it Read more December 17, 2021 News Four key strategies for Western biotechs to expedite drug development in China Home to a booming clinical trials market, China presents a huge opportunity for clinical innovati Read more February 20, 2020 News Novotech Partners with National Taiwan University Hospital (NTUH) to Support Biotech Clinical… Taipei, Taiwan – Asia-Pacific specialist CRO Novotech announced today that leadi Read more Solution Laboratory Services October 29, 2021 FAQ Virtual Clinical Trials in Asia and Australia The COVID-19 pandemic has had an impact on clinical trials around the world with the research and medical industry having to adapt to the ongoing challenges. Read More April 1, 2021 News Starting Your Clinical Journey With The End In Mind – The Value Of A Drug Development Plan Establishing an intelligent clinical development program pathway from the start is vital for clar Read more March 15, 2023 Webinar Keeping Pace With The Evolving Global Landscape In Vaccine Development Kari Abitbol: Hi, everyone. Watch June 6, 2022 News Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in… Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has rec Read more February 7, 2022 FAQ Clinical Development Strategies for Western Biotech Companies in China Since 2015, the medical and research industries in China have seen a huge shift with their regulatory processes and framework, which is helping to pave the way for Western biotechnology companies t Read More August 27, 2019 Whitepaper Australia: Preferred Destination for Early Phase Clinical Trials The clinical trials process is complex. It requires substantial investment and skilled human re-sources, and involves risks, not least, the navigation of complex regulatory processes. Download May 30, 2022 Webinar Development and Regulatory Strategy for US and China Speakers and Panelists Bio: Watch June 10, 2020 Webinar Clinical Trial Continuity in Asia-Pacific June 2020 Arsalan Arif: Hi everyone, I am Arsalan Arif, the founder and publisher of EndPoints serie Watch June 10, 2021 FAQ What is a Trial Master File? (TMF) A Trial Master File (TMF) is a compilation of documents that prove that the clinical trial has been conducted following regulatory requirements (including Good Clinical Practice). Read More February 25, 2019 News Novotech signs MOU with South Korea’s SCI-Consortium and Severance Hospital 31 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO No Read more March 2, 2022 FAQ What is the Driving Force Behind China’s Biotech Revolution? In 2011, China stated that its biomedicine industry was one of seven strategic priorities, and in its Five-Year Plan (2015-2020), the Chinese government mandated that the biotechnology sector should exceed 4% of GDP (Gross Domestic Product) by 2020 in market size. Read More April 1, 2022 FAQ Clinical Trends of 2022 2022 marks the third year of the worldwide COVID-19 pandemic, which continues to fuel the transformation of the clinical trial and the research industry. Read More Load More